Prevalence of chronic hepatitis B infection in Iran: a review article
<font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><ul><li><div align="left">Hepatitis B virus infection is a major public health problem worldwide. Islamic Re...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2009-08-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://journals.mui.ac.ir/jrms/article/view/2714 |
id |
doaj-d59adfb25d3a4dae9106d83c61465c18 |
---|---|
record_format |
Article |
spelling |
doaj-d59adfb25d3a4dae9106d83c61465c182020-11-24T21:22:18ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362009-08-01144249258Prevalence of chronic hepatitis B infection in Iran: a review articleJalal PoorolajalReza Majdzadeh<font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><ul><li><div align="left">Hepatitis B virus infection is a major public health problem worldwide. Islamic Republic of Iran is a country in which hepatitisB prevalence is intermediate. The aim of this study is to assess prevalence of chronic hepatitis B infection in Iran according to demographic characteristics. All cross-sectional studies concerning&nbsp; revalence of chronic hepatitis B infection in Iran were included irrespective of date and language. The outcome of interest was prevalence of chronic hepatitis B infection confirmed by blood specimen positive for HBsAg. The prevalence of chronic hepatitis B infection was&nbsp; stimated about 1.7% or lower in general population; 0.8% (95% CI: 0.6% to 0.9%) in blood donors and 3.2% (95% CI: 2.3% to 4.1%) in intravenous drug users and varied from zero to 1.5% in beta thalassemic patients. Since mass vaccination in 1993, prevalence of chronic hepatitis B infection has being reduced among children and adolescents. This reduction can be attributed to the effectiveness of the national immunization program and it may impact on reduction of prevalence of hepatitis B infection in general population.</div></li><font face="TimesNewRoman,Bold" size="1"><font face="TimesNewRoman,Bold" size="1"><li><div align="left"><strong>KEY WORDS:</strong> <font face="BookAntiqua" size="2"><font face="BookAntiqua" size="2">Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran</font></font><font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><strong>.</strong></font></font></div></li></font></font></ul></font></font> http://journals.mui.ac.ir/jrms/article/view/2714Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jalal Poorolajal Reza Majdzadeh |
spellingShingle |
Jalal Poorolajal Reza Majdzadeh Prevalence of chronic hepatitis B infection in Iran: a review article Journal of Research in Medical Sciences Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran. |
author_facet |
Jalal Poorolajal Reza Majdzadeh |
author_sort |
Jalal Poorolajal |
title |
Prevalence of chronic hepatitis B infection in Iran: a review article |
title_short |
Prevalence of chronic hepatitis B infection in Iran: a review article |
title_full |
Prevalence of chronic hepatitis B infection in Iran: a review article |
title_fullStr |
Prevalence of chronic hepatitis B infection in Iran: a review article |
title_full_unstemmed |
Prevalence of chronic hepatitis B infection in Iran: a review article |
title_sort |
prevalence of chronic hepatitis b infection in iran: a review article |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Research in Medical Sciences |
issn |
1735-1995 1735-7136 |
publishDate |
2009-08-01 |
description |
<font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><ul><li><div align="left">Hepatitis B virus infection is a major public health problem worldwide. Islamic Republic of Iran is a country in which hepatitisB prevalence is intermediate. The aim of this study is to assess prevalence of chronic hepatitis B infection in Iran according to demographic characteristics. All cross-sectional studies concerning&nbsp; revalence of chronic hepatitis B infection in Iran were included irrespective of date and language. The outcome of interest was prevalence of chronic hepatitis B infection confirmed by blood specimen positive for HBsAg. The prevalence of chronic hepatitis B infection was&nbsp; stimated about 1.7% or lower in general population; 0.8% (95% CI: 0.6% to 0.9%) in blood donors and 3.2% (95% CI: 2.3% to 4.1%) in intravenous drug users and varied from zero to 1.5% in beta thalassemic patients. Since mass vaccination in 1993, prevalence of chronic hepatitis B infection has being reduced among children and adolescents. This reduction can be attributed to the effectiveness of the national immunization program and it may impact on reduction of prevalence of hepatitis B infection in general population.</div></li><font face="TimesNewRoman,Bold" size="1"><font face="TimesNewRoman,Bold" size="1"><li><div align="left"><strong>KEY WORDS:</strong> <font face="BookAntiqua" size="2"><font face="BookAntiqua" size="2">Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran</font></font><font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><strong>.</strong></font></font></div></li></font></font></ul></font></font> |
topic |
Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran. |
url |
http://journals.mui.ac.ir/jrms/article/view/2714 |
work_keys_str_mv |
AT jalalpoorolajal prevalenceofchronichepatitisbinfectioniniranareviewarticle AT rezamajdzadeh prevalenceofchronichepatitisbinfectioniniranareviewarticle |
_version_ |
1725996344896651264 |